Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early Arthritis
- Sponsor
- Goupe d'Etudes et de Recherche Clinique En Rhumatologie
- Study ID
- NCT00291915
- Phase
- PHASE4
- Status
- Unknown
Conditions
- Arthritis
- Rheumatoid Arthritis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Adalimumab — DRUG
- Methotrexate — DRUG
Study Details
Evaluation of two treatment modalities in early potentially severe early arthritis ( Methotrexate alone or in combination with adalimumab)
Key Dates
- Start date
- May 31, 2004
- Status verified
- Feb 2006
- Completion
- Mar 31, 2007
Study Design
- Enrollment
- 80 participants
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Primary Outcome Measure
Disease Activity Score
Central Contacts
- Maxime r DOUGADOS, MD00 33 1 58 41 25 62
- Martin SOUBRIER, MD00 33 6 81 74 78 85
Related Studies
- Studies of the Natural History of Rheumatic DiseasesRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts
- Natural History and Development of SpondyloarthritisRecruiting · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Bethesda, Maryland
- Conjoint Analysis of Patient Preferences in Joint InterventionsEnrolling By Invitation · Duke University · Durham, North Carolina